Wellgistics Health

27/08/2026

As seasonal shifts approach, proactive health management is taking center stage. Datamedsai

We are excited to announce our Fall 2026 Cold & Flu direct-to-consumer initiative, in partnership with Tollo Health, highlighting the medical food Galectovid™ to support the dietary management of viral infections as communities gear up for the colder months.

Through integrated Health IT solutions and pharmacist-supported channels via Corexa Pharmacy, making targeted, science-backed immune health resources accessible has never been more vital.

Read More: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/correction-from-source-datameds-ai-and-tollo-health-announce-fall-202-1213212

20/08/2026

US prescription drug prices have recorded a steep drop, falling 3.1% from a year ago. Datamedsai Interim CEO Gerald Commissiong recently joined NTD News to break down these shifting market dynamics.

During the discussion, he highlighted that the primary driver behind the decline is the smooth shift of the GLP-1 market toward cash pay, alongside ongoing negotiations around Medicare payments that are reshaping pharmaceutical pricing. $MEDS

Watch the full interview to explore how these trends are transforming the industry.

13/08/2026

As we continue our journey, a quick reminder that Wellgistics Health is now DataMeds AI.

Follow Datamedsai for our latest updates as we build a vertically integrated healthcare ecosystem designed to empower patients with control over their health information. $MEDS

12/08/2026

Pro Football Hall of Fame runningback Emmitt Smith and DataMeds AI interim co-CEO Gerald Commissiong discuss their new app, Health Lives Here, on ‘The Claman Countdown.’

12/08/2026

Today, our pharmaceuticals-focused subsidiary Corexa Pharmacy has achieved several significant milestones that position it to be the centerpiece of our growth in the 2nd half of 2026. Some of these include:

- The launch of the online store CorexaRx.com/Store and its integration into the Health Lives Here App
- Registration with TrumpRx to be able to offer patients access to oral GLP-1 agonist drugs, such as Eli Lilly’s Foundayo® and Novo Nordisk’s oral Wegovy, for as little as $149 out of pocket costs.
- Availability of GLP-1 agonist companion medical food Forzet®, manufactured by Tollo Health to complement patients’ use of GLP-1 agonist drugs for the dietary management of muscle loss associated with weight loss therapies.
$MEDS

For more details, read the complete announcement here: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/datameds-ai-provides-update-on-corexa-healths-pharmacy-division-1206399

07/08/2026

It was a pleasure to join The Claman Countdown on Fox Business alongside NFL Pro Football Hall of Fame running back Emmitt Smith to talk about Datamedsai's app.

Recognizing that many rural areas lack sufficient access to healthcare, and noting that a significant number of NFL alumni reside in these communities, this collaboration proved to be the perfect partnership to extend vital health resources where they are needed most.

As part of tackling those broader health data privacy concerns, users need a platform they can genuinely trust. Seeing the critical need for an integrated health app that puts the user first, DataMeds AI developed Health Lives Here to seamlessly empower individuals in managing their personal health while uniquely offering a piece of revenue directly back to the consumer.

Catch the full conversation and breakdown with Cheryl Casone:

Pro Football Hall of Fame runningback Emmitt Smith and DataMeds AI interim co-CEO Gerald Commissiong discuss their new app, Health Lives Here, on ‘The Claman Countdown.’

05/08/2026

Tune in to Fox Business today at 3 PM ET!

DataMeds AI Interim Co-CEO Gerald Commissiong & Pro Football Hall of Fame legend Emmitt Smith join Liz Claman on The Claman Countdown to launch our new "Health Lives Here" initiative with NFL Alumni Health ahead of Hall of Fame Weekend! $MEDS

Photo Credit: Fox Business

Learn how we're using AI to improve rural healthcare access: https://hubs.la/Q04rZnd00

31/07/2026

DataMeds AI’s Corexa Pharmacy Launches Tollo Health’s Tollovid® and Galactovid™ $MEDS $WGRX

Read our full press release for complete details and disclosures: https://hubs.ly/Q04rtlDK0

29/07/2026

DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License. $MEDS $WGRX

Read our full press release for complete details and disclosures: https://hubs.la/Q04r86gx0

22/07/2026

DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets.

Read our full press release for complete details and disclosures: https://hubs.ly/Q04qlPhz0